SCRA today announced its first tenant to lease space at the SCRA Applied
Technologies Center at Nexton in Summerville, S.C., which is currently
under construction. Aeterna Zentaris will occupy the third floor of the
building and is scheduled to move in upon completion of the new facility
Aeterna Zentaris (NASDAQ: AEZS, TSX: AEZ) is a Canadian specialty
biopharmaceutical company engaged in developing novel treatments in
oncology and endocrinology. With operations in Quebec City Canada and
Frankfurt, Germany, the company recently established its North American
business and global commercial operations in Charleston, South Carolina,
in early June. Approximately 60 direct jobs are expected in the state
over the next few years.
Company Chairman and CEO, David Dodd, is a S.C. Low country resident and
has successfully led multiple biopharmaceutical ventures throughout his
career. These include: Wyeth, Solvay Pharmaceuticals, Serologicals
Corporation, BioReliance Corporation and ther operations where he has
either served as an executive or board member.
"We are delighted to locate operations at the beautifully designed and
easily accessible SCRA Applied Technologies Center," said Dodd. "We look
forward to working with SCRA and contributing to the local economy."
SCRA broke ground at the Nexton campus in October of 2013 and expects to
complete construction in September of 2014. The Applied Technologies
Center will house SCRA Charleston-area operations and the majority of
the company's Charleston-area employees. Tenant companies will lease
space as it is available.
"SCRA is pleased to welcome Aeterna Zentaris to South Carolina," said
SCRA CEO Bill Mahoney. "This outstanding company is developing life
changing technologies and will be a significant cog in South Carolina's
SCRA is an applied research corporation with over 30 years of experience
delivering technology solutions with high returns on investment to
federal and corporate clients. To fulfill our mission, SCRA has three
sectors: Our Technology Ventures sector has helped over 290 early-stage
companies to commercialize innovations and create jobs, our Applied R&D
sector manages over 100 national and international programs worth over
$2 billion in contract value, and our R&D Facilities sector builds and
manages research facilities that include wet labs, secure rooms for
sensitive work and advanced, high-tech manufacturing shops. Multiple
economic impact studies show SCRA's cumulative output into South
Carolina's economy to be over $16.6 billion.
[ Back To NFVZone's Homepage ]